Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/10 16:31 | 8/10/10 | HEB | Health | BioPrd | Biological Products, (No Diag | Carter William A | PA | DOT | CEO | S.m | -187 | 0.4948 | 0 | -377 | -17 | 1,780 | M | -27 | -76 | -28 | -32 | 7 | 0 | -8 | -4 | 2 | 0 | 6 | 4 | 2 | -43 |
6/24/10 11:09 | 6/22/10 | HEB | Health | BioPrd | Biological Products, (No Diag | Strayer David R | PA | H | Medical | S.m | -28 | 0.5501 | 0 | -51 | -18 | 231 | D | -27 | -73 | -13 | -29 | -28 | -17 | -9 | -9 | -2 | -11 | 0 | -4 | -6 | -25 |
6/16/10 16:53 | 6/15/10 | HEB | Health | BioPrd | Biological Products, (No Diag | Springate Wayne S. | PA | O | VP of Op | S | -49 | 0.5910 | 0 | -83 | -45 | 104 | D | -16 | -78 | 0 | -19 | -20 | -8 | -3 | -2 | 0 | -3 | -17 | -7 | -12 | -32 |
6/16/10 16:21 | 6/15/10 | HEB | Health | BioPrd | Biological Products, (No Diag | Bernhardt Charles Thomas III | PA | O | CFO | S | -52 | 0.5920 | 0 | -88 | -33 | 177 | D | -16 | -78 | 0 | -19 | -20 | -8 | -3 | -2 | 0 | -3 | -17 | -7 | -12 | -32 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |